ISRG
73
2
SIG
84
2
ES
41
-2
BA
52
3
MMC
64
2
AN
63
2
DG
30
2
AAL
48
3
GWW
60
7
HUM
47
2
WU
52
-4
PSA
48
5
BSX
71
2
DOW
60
2
WMT
62
-5
ALLE
53
9
GPC
47
-7
DHI
52
2
VRSK
80
3
UPS
53
-3
ISRG
73
2
SIG
84
2
ES
41
-2
BA
52
3
MMC
64
2
AN
63
2
DG
30
2
AAL
48
3
GWW
60
7
HUM
47
2
WU
52
-4
PSA
48
5
BSX
71
2
DOW
60
2
WMT
62
-5
ALLE
53
9
GPC
47
-7
DHI
52
2
VRSK
80
3
UPS
53
-3
Financhill
Back

PTC Therapeutics Stock Predictions

Buy
59

PTCT
PTC Therapeutics

Last Price:
33.67
Seasonality Move:
23.62%

7 Day Trial

ALL ACCESS PASS

$ 7

PTC Therapeutics Stock Forecast

  • Over the next 52 weeks, PTC Therapeutics has on average historically risen by 40.7% based on the past 10 years of stock performance.
  • PTC Therapeutics has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is PTC Therapeutics Stock Undervalued?
    The current PTC Therapeutics [PTCT] share price is $31.18. The Score for PTCT is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • PTCT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will PTC Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, PTC Therapeutics has on average historically risen by 40.7% based on the past 10 years of stock performance.

PTC Therapeutics Stock Rating

Buy
59
PTC Therapeutics (PTCT) is a Buy

Is PTC Therapeutics overpriced?

  • PTC Therapeutics has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

PTC Therapeutics Stock Price History

Is PTCT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ptcbio.com

52-Week Data

52-Week High:
59.84
52-Week Low:
17.53

Prediction Charts

Market Cap:
2.39B
Price in USD:
31.18
Volume:
497.82K
Beta:
0.86

Technical Analysis

SMA50:
29.18
SMA100:
28.25
SMA200:
28.26
52-Wk Change:
-42.98%

Stock Predictions

  • Is PTC Therapeutics stock public?
    Yes, PTC Therapeutics is a publicly traded company.
  • What is the PTC Therapeutics stock quote today?
    The PTC Therapeutics stock price is 31.18 USD today.
  • How to buy PTC Therapeutics stock online?
    You can buy PTC Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-25 24.66 25.49 25.65 24.00
Apr-26 27.00 28.57 29.27 25.67
Apr-29 29.40 32.14 32.61 29.08
Apr-30 31.96 32.16 32.88 31.70
May-1 32.31 34.16 35.47 31.70
May-2 34.73 33.62 34.90 33.21
May-3 34.73 33.01 34.83 32.81
May-6 32.96 32.98 33.32 32.54
May-7 33.16 31.79 33.30 31.70
May-8 31.13 31.14 31.60 30.71
May-9 31.14 31.06 31.39 30.79
May-10 31.23 32.25 32.69 31.01
May-13 32.25 31.70 33.26 31.48
May-14 32.54 31.18 33.13 30.95

PTC Therapeutics Earnings

PTC Therapeutics Earnings Report: Per Share PTC Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

PTC Therapeutics Forecast Revenue Growth

PTC Therapeutics Stock Analysis: Historical quarterly revenues per share for PTC Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.47 per share, an increase next quarter of $0.44 per share, a decrease this year of $0.61 per share, and an increase next year of $1.56 per share.

* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.